Hematology/Oncology Fellows 2007

All trainees participate in a variety of educational experiences and rotations. All trainees are provided with guidance, supervision and mentoring as they train to become a subspecialist in the broad field of hematology/oncology.

Hematology and Oncology Fellowship Program

The major objective of the Stanford University Hematology and Oncology Fellowship Program is to train leaders in academic hematology/oncology. Fellows should achieve excellence in the practice of hematology/oncology and acquire the skills necessary for independent and productive investigation. To accomplish these goals, fellows are supported for three years. Hematology and Medical Oncology are divisions in the Department of Medicine at the Stanford University School of Medicine. Both divisions have ACGME-accredited fellowship programs.

As a private institution, Stanford University has a strong and ongoing commitment to the principle of diversity. In that spirit, we especially encourage applications from all people including women, members of ethnic minority groups, and disabled persons.

Separate Oncology and Hematology Programs offer flexibility

Stanford’s fellowship programs in Medical Oncology and Hematology are separate programs whose primary objective is to prepare academic oncologists and hematologists. Our fellowship program is very flexible, and fellows may choose to train in hematology and/or oncology. For those choosing to pursue combined training, the programs are fully integrated.

Program Requirements

The three-year hematology or oncology program is an intensive training period in clinical care and research. Combined training in hematology/oncology requires 18 months of clinical training and additional time for intensive research training. Applicants to the program will be expected to have completed an internal medicine residency program. Previous investigative experience is helpful. You must have a California medical license prior to the starting date of your fellowship (July 1).

Due to NIH funding restrictions, ALL hematology and oncology applicants must be either United States citizens or have permanent resident status in the United States by the beginning date of their fellowship training. There are no exceptions.

All fellows must be funded through the Divisions of Hematology and Oncology. The School of Medicine does not allow self-funded fellows.


ERAS: All applications should come to us through ERAS (Electronic Residency Application Service). We will be participating in the NRMP Match.

Timeframe: We will accept applications from July 15 to August 31.

Interviews: Your application will be reviewed, and selected applicants will be contacted to schedule interviews. If you are invited for an interview, you may find this list of hotels/motels useful.

Program Structure

The Division of Hematology has 14 full-time faculty and 25 postdoctoral fellows involved in clinical or research training. The Division of Medical Oncology has 28 full-time faculty, 17 adjunct clinical faculty, and 35 postdoctoral fellows engaged in clinical or research training. There are active programs covering a broad range of modern cancer patient care and clinical and laboratory research.

Educational Component

The educational program is supported by a wide variety of educational conferences, lectures, journal clubs, and required classes.

Clinical Training Component

Outpatient care and clinical investigations for ambulatory cancer patients are conducted at the Comprehensive Cancer Clinic.

Research Training Component

Hematology and Oncology fellows may pursue research projects within the Divisions or anywhere throughout the Medical School or University.